J&J crossed by Red Cross?
This article was originally published in The Gray Sheet
Johnson & Johnson is suing the American Red Cross for violating its exclusive trademark rights to the Red Cross design and use of the word "Red Cross" on commercial products. The suit, filed Aug. 8 in New York federal court, cites ARC's licensing of the trademark - used by J&J on first-aid supplies since 1887 - to businesses selling products including baby mitts, combs and humidifiers, and notes the organization only has rights to the emblem in connection with non-profit relief services. ARC called the suit "obscene," explaining that it has taken the step to license the emblem to expand access to emergency preparedness supplies...
You may also be interested in...
The American Red Cross can lawfully use its Red Cross emblem on commercial products, despite J&J's contention that it violates its rights to the design, New York federal judge Jed Rakoff rules May 14. J&J filed the suit in August 2007 (1"The Gray Sheet" Aug. 13, 2007, In Brief). Rakoff ruled against American Red Cross counterclaims that Johnson & Johnson was violating the trademark rights
As the global shut-down caused by the coronavirus pandemic continues, sponsors are rushing to adapt clinical trials that can move to partial or completely remote monitoring, allowing patients to remain in their homes but continue to participate in studies. And the outbreak may have another silver lining for the biopharma industry, a chance to rebuild its reputation.
The arrival of SARS-CoV-2 has focused attention on a potential new way of making vaccines – one that promises to be quicker and cheaper than traditional methods and more reactive to novel virus outbreaks, but also one that remains to be validated.